PMID: 8601269Dec 1, 1995Paper

ASHP therapeutic position statement on strict glycemic control in selected patients with insulin-dependent diabetes mellitus

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists

Abstract

ASHP supports strict glycemic control in selected patients with IDDM on the basis of studies demonstrating that strict glycemic control delays the onset and slows the progression of diabetic retinopathy, nephropathy, and neuropathy. Because of the increased risk of hypoglycemia, intensive treatment regimens may not be appropriate in patients with poor perception of hypoglycemic symptoms and those with a history of frequent, severe hypoglycemic episodes. The pharmacist can play a key role in implementing and monitoring this therapy by collaborating with other members of the health care team and by counseling patients.

Citations

May 17, 2006·Pharmacy World & Science : PWS·Michiel J StorimansCornelis J de Blaey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Related Papers

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
American Society of Health-System Pharmacists
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
© 2021 Meta ULC. All rights reserved